In a study involving patients with NAFLD (non-alcoholic fatty liver disease) given 300 mg of glutathione daily for 4 months, there were significant reductions in ALT (a liver enzyme that is elevated with liver damage), triglycerides, and ferritin
Heres what the science says
Given the multiplicity of sites that can mediate opioid analgesia (peripheral, spinal, brain stem, and cortical sites), it is likely that differences in physical and pharmacokinetic properties of different agonists, including hydrophobicity, could result in bias with respect to regions of receptor availability
For fat loss, pair a GLP-1 agonist with BPC-157 for GI protection
Patients experiencing persistent fatigue, fluid retention, shortness of breath, or difficulties maintaining proper nutrition due to CHF can benefit from this tailored approach
Support for Chronic Illness Low glutathione levels are linked to conditions like Parkinsons disease, Alzheimers, autoimmune disorders, and even cancer progression
